Normal Saline for Parenteral Use Market Size & Share

1. The global normal saline for parenteral use market is projected to grow from $3.91 billion in 2025 to $6.33 billion by 2032, with a CAGR of 7.1%. North America dominates with a 39.24% market share, driven by established healthcare infrastructure and high usage - approximately 200 million liters of saline sold annually in the US alone. Key market segments include:  By Type: Plastic bottles (dominant segment) and glass bottles  By Application: Intramuscular and intravenous injection  By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa Major market drivers:  Rising hospital admissions and surgical procedures  Increasing cases of dehydration and sepsis  Growing demand during flu seasons, with up to 50 million infections annually in the EU  Expanding healthcare infrastructure in developing regions Leading companies include:  Baxter (market leader)  Kelun Group  B. Braun Melsungen AG  Fresenius Kabi AG  SSY Group Limited COVID-19 negatively impacted the market as elective surgeries declined, with an estimated 28.4 million surgeries cancelled globally during peak disruption. However, the market is recovering, though some studies suggesting replacement of saline with balanced fluids may constrain growth. Report: Fortune Business Insights - Normal Saline for Parenteral Use Market Growth Report https://www.fortunebusinessinsights.com/normal-saline-for-parenteral-use-market-104520